University of Miami Miller School of Medicine and Sylvester Comprehensive Cancer Center, Miami, FL, USA.
University of Miami Miller School of Medicine and Sylvester Comprehensive Cancer Center, Miami, FL, USA.
Eur Urol Focus. 2017 Feb;3(1):94-99. doi: 10.1016/j.euf.2015.12.005. Epub 2016 Jan 6.
The 4Kscore accurately predicts aggressive prostate cancer (PCa) on prostate biopsy.
We assessed how well the 4Kscore predicts pathology at radical prostatectomy (RP).
DESIGN, SETTING, AND PARTICIPANTS: Among 1312 men who prospectively underwent a 4Kscore and biopsy of the prostate at 26 sites throughout the United States from October 2013 to April 2014, we selected men who were diagnosed with cancer and underwent RP.
The primary outcome was the presence of high-grade PCa or extracapsular extension. We assessed the association between the 4Kscore and the grade and extent of PCa at RP using the Wilcoxon rank sum test. We used logistic regression to investigate the added value of the 4Kscore in predicting a high-grade or non-organ-confined tumor when added to available postbiopsy clinical predictive tools.
A total of 144 men were diagnosed with PCa and underwent RP. Higher 4Kscores were associated with higher grade at RP. For men with Gleason scores ≥6, 7, and 8 cancers in the surgical specimen, the median 4Kscores were 7% (interquartile range [IQR]: 4-2), 25% (IQR: 12-38), and 47% (IQR: 24-66) (p<0.0001), respectively. The median 4Kscore among men with non-organ-confined cancer was significantly higher then men with organ-confined cancers (36% [IQR: 19-58] vs 19% [IQR: 9-35]; p=0.002). The 4Kscore did not significantly add to available clinical prediction tools for determining the likelihood of a high grade or non-organ-confined cancer; however, we were limited by a small sample size for this analysis.
In a subset of men who underwent RP, the 4Kscore was significantly associated with pathologic grade and extracapsular extension in the surgical specimen, with higher scores associated with higher grade and more aggressive histology. The 4Kscore test may be helpful in selecting men who are likely to have adverse pathologic features at RP that may preclude them from being safely observed.
Among men with prostate cancer who underwent removal of the prostate, the 4Kscore was associated with the final grade and extent of cancer.
4Kscore 可准确预测前列腺活检中的侵袭性前列腺癌(PCa)。
我们评估 4Kscore 在根治性前列腺切除术(RP)中的预测病理的效果。
设计、地点和参与者:在 2013 年 10 月至 2014 年 4 月期间,在美国 26 个地点前瞻性接受 4Kscore 和前列腺活检的 1312 名男性中,我们选择了诊断为癌症并接受 RP 的男性。
主要结局是高级别 PCa 或包膜外延伸。我们使用 Wilcoxon 秩和检验评估 4Kscore 与 RP 时 PCa 的分级和程度之间的关联。我们使用逻辑回归来研究 4Kscore 在加入可用的活检后临床预测工具时对预测高级别或非器官受限肿瘤的附加价值。
共有 144 名男性被诊断为 PCa 并接受 RP。较高的 4Kscore 与 RP 时的较高分级相关。对于在手术标本中具有 Gleason 评分≥6、7 和 8 癌症的男性,中位 4Kscore 分别为 7%(四分位距[IQR]:4-2)、25%(IQR:12-38)和 47%(IQR:24-66)(p<0.0001)。非器官受限癌症男性的中位 4Kscore 明显高于器官受限癌症男性(36%[IQR:19-58]vs 19%[IQR:9-35];p=0.002)。4Kscore 并未显著增加用于确定高级别或非器官受限癌症可能性的可用临床预测工具;然而,我们的分析受到样本量小的限制。
在接受 RP 的男性亚组中,4Kscore 与手术标本中的病理分级和包膜外延伸显著相关,评分较高与较高的分级和更具侵袭性的组织学相关。4Kscore 测试可能有助于选择可能在 RP 中具有不良病理特征从而使他们无法安全观察的男性。
在接受前列腺切除术的前列腺癌男性中,4Kscore 与癌症的最终分级和程度相关。